BCLS II Investo (GP), LLC

Historique de performance de BCLS II Investo (GP), LLC

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de BCLS II Investo (GP), LLC

Co-initiés de BCLS II Investo (GP), LLC

• Bain Capital Life Sciences Fund II, L.P.NewAmsterdam Pharma Co N.V. +2
• Bain Capital Life Sciences Investors II, LLCNewAmsterdam Pharma Co N.V. +2
• Bain Capital Life Sciences Investors, LLCNewAmsterdam Pharma Co N.V. +2
• BCIP Life Sciences Associates, LPNewAmsterdam Pharma Co N.V. +2
• BCLS II Investco, LPNewAmsterdam Pharma Co N.V. +2
• Adage Capital Management, L.P.Solid Biosciences Inc.
• Alexandria Venture Investments, LLCXilio Therapeutics, Inc.
• Amorrortu Pedro AlvaroSolid Biosciences Inc.
• Arnold Matthew BennettSolid Biosciences Inc.
• Atchinson RobertSolid Biosciences Inc.
• Atlas Venture Associates Opportunity I, LLCXilio Therapeutics, Inc.
• Atlas Venture Associates Opportunity I, L.P.Xilio Therapeutics, Inc.
• Atlas Venture Associates XI, LLCXilio Therapeutics, Inc.
• Atlas Venture Associates XI, L.P.Xilio Therapeutics, Inc.
• Atlas Venture Fund XI, L.P.Xilio Therapeutics, Inc.
• Atlas Venture Opportunity Fund I, L.P.Xilio Therapeutics, Inc.
• Audet Juliette BerangereNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Fund III, L.P.NewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences III General Partner, LLCNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Partners, LPSolid Biosciences Inc.
• BAY CITY CAPITAL LLCXilio Therapeutics, Inc.
• BCLS Fund III Investments GP, LLCNewAmsterdam Pharma Co N.V.
• BCLS Fund III Investments, LPNewAmsterdam Pharma Co N.V.
• BCLS II Equity Opportunities GP, LLCSolid Biosciences Inc.
• BCLS II Equity Opportunities, LPSolid Biosciences Inc.
• BCLS SB Investco, LPSolid Biosciences Inc.
• Bello Akintunde OlatokumboXilio Therapeutics, Inc.
• Blanchard Cheryl RXilio Therapeutics, Inc.
• Bonstein SaraXilio Therapeutics, Inc.
• Boxer Asset Management Inc.Solid Biosciences Inc.